Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
The S&P 500 fell as fresh inflation data surprised to the upside, triggering a broad risk-off move and reshaping near...
DRAM prices in Korea jumped nearly 500% year over year as Micron, Samsung, and SK Hynix tighten control, turning memo...
A notable fund manager recently exited an ETF position in a move that grabbed attention across the investing world. T...
When markets punish uncertainty, contrarian investors can find hidden upside. This article highlights three strugglin...
President Trump arrives in Beijing for high-stakes talks with Xi Jinping, pressing to open up China for American inve...
The phrase oklo stock sinking today captures the mood around Oklo’s latest earnings and market reaction. This guide b...
Cardano’s ADA hovers around 26 cents as large holders bolster their positions. While the token remains down about 70%...
Brookfield's 2026 earnings path blends renewable energy growth with infrastructure and asset management fees. This gu...
Figma trades higher ahead of tonight’s Q1 print, as analysts eye revenue growth and AI momentum. Live coverage tracks...
OKX is close to purchasing a 20% stake in Coinone, a leading South Korean crypto exchange. The deal, still under regu...
Brokerage consolidations are shifting leverage toward agents as new split and autonomy models emerge. This report exa...